Results 151 to 160 of about 31,957 (244)
Additive value of early-phase β-Amyloid-PET for the differential diagnosis of non-Alzheimer's disease dementia. [PDF]
Eckenweber S +21 more
europepmc +1 more source
Sex-specific effects of acetylation on tauopathy in aging htau mice. [PDF]
Sabir U +8 more
europepmc +1 more source
Neurodegenerative diseases, of which tauopathies form a major class, are increasing in prevalence worldwide. Tauopathies are characterized by the presence of abnormal neuronal and glial inclusions that are composed predominantly of the microtubule associated protein, tau. Several foci of increased incidence of tauopathies have been identified that have
openaire +1 more source
Female-specific <i>Cx3cr1</i>-driven regulation of ALS and Alzheimer's risk genes in tauopathy. [PDF]
Sudwarts A, Thinakaran G.
europepmc +1 more source
Classification of tauopathies from human brain homogenates through salt-modulated tau amplification. [PDF]
Santambrogio A +8 more
europepmc +1 more source
Region-specific ups and downs in mitochondrial numerical densities during Alzheimer's disease progression: A pilot study in human brains. [PDF]
Balsliemke AL +5 more
europepmc +1 more source
Protein production is an early biomarker for RNA‐targeted therapies [PDF]
Alex, Jacob +10 more
core +2 more sources
Immune signaling and function in neurodegeneration. [PDF]
Latour YL, McGavern DB.
europepmc +1 more source

